JENNIFER HANNESSCHLAGER — Lobbyist Profile | Poliscope

JENNIFER HANNESSCHLAGER

Reported covered position: N/A

Filings

Clients

Firms

Years active

2006–2009

Associated filing income

$3,510,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
IMPLICIT CORPORATION	12	2006–2009
CHIMERIX, INC.	10	2007–2009
EMERGENT BIOSOLUTIONS INC.	9	2007–2009
MEDIMMUNE INC	8	2007–2009
ALLERGAN	7	2007–2009
HUMAN GENOME SCIENCES	7	2007–2008

Lobbying firms

Firm	Filings	Years
MCKENNA, LONG & ALDRIDGE	80	2006–2009

Bills explicitly cited in this lobbyist’s assigned issues (4)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

S. 3127

Select Agent Program and Biosafety Improvement Act of 2008

Client: ALLERGAN · Firm: MCKENNA, LONG & ALDRIDGE

Open original LDA filing ↗

Cited source text

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S.3127

S. 3127

Select Agent Program and Biosafety Improvement Act of 2008

Client: ALLERGAN · Firm: MCKENNA, LONG & ALDRIDGE

Open original LDA filing ↗

Cited source text

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S. 3127

Original LDA source filings (80)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1@

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

HCR

Health Issues

funding for Antiviral and Antimicrobial products

DEF

Defense

funding for Antiviral and Antimicrobial products

Source: Senate LDA

Show 76 more original filings

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1T

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

HCR

Health Issues

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1T

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1T

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · Q1

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

OXITEC via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1T

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solution using sterilization techniques

Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

funding for Antiviral and Antimicrobial products

HCR

Health Issues

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · Q1

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act

HOM

Homeland Security

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2009 · first_quarter · 1T

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · 2A

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S. 3127

HOM

Homeland Security

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S. 3127

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · 2A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

federal policy regarding anthrax therepeutics

HCR

Health Issues

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008

HCR

Health Issues

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OXITEC via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solution using sterilization techniques

Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

OSIRIS THERAPEUTICS INC via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Bioterrorism policy, procurement of therapeutics by federal government

HOM

Homeland Security

Bioterrorism policy, procurement of therapeutics by federal government

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

HCR

Health Issues

funding for Antiviral and Antimicrobial products

DEF

Defense

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

federal policy regarding anthrax therepeutics

HOM

Homeland Security

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2008 · fourth_quarter · Q4

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008

HCR

Health Issues

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OXITEC via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solution using sterilization techniques

Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

funding for Antiviral and Antimicrobial products

HCR

Health Issues

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

OSIRIS THERAPEUTICS INC via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Bioterrorism policy, procurement of therapeutics by federal government

HOM

Homeland Security

Bioterrorism policy, procurement of therapeutics by federal government

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

federal policy regarding anthrax therepeutics

HOM

Homeland Security

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2008 · third_quarter · Q3

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OXITEC via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solution using sterilization techniques

Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

funding for Antiviral and Antimicrobial products

DEF

Defense

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SMITHS DETECTION via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · 2T

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

education of federal government about BioDefense, Homeland Security, and Related Biodetection Technologies

HCR

Health Issues

education of federal government about BioDefense, Homeland Security, and Related Biodetection Technologies

Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · 2A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

federal policy regarding anthrax therepeutics

HOM

Homeland Security

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

federal policy regarding anthrax therepeutics

HCR

Health Issues

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S.3127

HCR

Health Issues

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S.3127

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OSIRIS THERAPEUTICS INC via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Bioterrorism policy, procurement of therapeutics by federal government

HOM

Homeland Security

Bioterrorism policy, procurement of therapeutics by federal government

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2008 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · 1A

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · 1A

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

DEF

Defense

funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

federal policy regarding anthrax therepeutics

HCR

Health Issues

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OSIRIS THERAPEUTICS INC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Bioterrorism policy, procurement of therapeutics by federal government

HCR

Health Issues

Bioterrorism policy, procurement of therapeutics by federal government

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

public health issues impacting pharmaceuticals

HOM

Homeland Security

public health issues impacting pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

GALEN BIO via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Federal policies regarding bioterrorism and vaccine production

HCR

Health Issues

Federal policies regarding bioterrorism and vaccine production

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OXITEC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solution using sterilization techniques

Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

SMITHS DETECTION via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

BioDefense, Homeland Security, and Related Biodetection Technologies

HOM

Homeland Security

BioDefense, Homeland Security, and Related Biodetection Technologies

Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · Q1

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

OXITEC via MCKENNA, LONG & ALDRIDGE

2008 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

issues related to biotechnology and biological insect control solutions using sterilization techniques

ALLERGAN via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

public health issues impacting pharmaceuticals

HOM

Homeland Security

public health issues impacting pharmaceuticals

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YA

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YA

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YA

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

SMITHS DETECTION via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

BioDefense, Homeland Security, and Related Biodetection Technologies

HCR

Health Issues

BioDefense, Homeland Security, and Related Biodetection Technologies

Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HOM

Homeland Security

Funding for Antiviral and Antimicrobial products

DEF

Defense

Funding for Antiviral and Antimicrobial products

HCR

Health Issues

Funding for Antiviral and Antimicrobial products

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HUMAN GENOME SCIENCES via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

federal policy regarding anthrax therepeutics

HOM

Homeland Security

federal policy regarding anthrax therepeutics

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

GALEN BIO via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Federal policies regarding bioterrorism and vaccine production.

HOM

Homeland Security

Federal policies regarding bioterrorism and vaccine production.

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

EMERGENT BIOSOLUTIONS INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Education of federal agencies regarding anthrax vaccine technology

HCR

Health Issues

Education of federal agencies regarding anthrax vaccine technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

ADVANCED LIFE SCIENCES INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Federal policies impacting antibiotics and other pharmaceuticals

HCR

Health Issues

Federal policies impacting antibiotics and other pharmaceuticals .

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

CHIMERIX, INC. via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

education of federal agencies regarding smallpox therapeutic technology

HOM

Homeland Security

education of federal agencies regarding smallpox therapeutic technology

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

MEDIMMUNE INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

federal policy regarding influenza vaccination

HCR

Health Issues

federal policy regarding influenza vaccination

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

OSIRIS THERAPEUTICS INC via MCKENNA, LONG & ALDRIDGE

2007 · year_end · YY

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HOM

Homeland Security

Bioterrorism policy, procurement of therapeutics by federal government

HCR

Health Issues

Bioterrorism policy, procurement of therapeutics by federal government

Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office

GALEN BIO via MCKENNA, LONG & ALDRIDGE

2007 · year_end · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

Federal policies regarding bioterrorism and vaccine production.

SMITHS DETECTION via MCKENNA, LONG & ALDRIDGE

2007 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HOM

Homeland Security

Biodefense, Homeland Security projects and biodetection technologies

Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2007 · mid_year · MM

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Funding for Antiviral and Antimicrobial Products

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2006 · mid_year · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

funding for Antiviral and Antimicrobial products

HOM

Homeland Security

funding for Antiviral and Antimicrobial products

DEF

Defense

funding for Antiviral and Antimicrobial products

SMITHS DETECTION via MCKENNA, LONG & ALDRIDGE

2006 · year_end · YY

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

DEF

Defense

BioDefense, Defense, Homeland Security and Related Biodetection Technologies

Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2006 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Funding for Antiviral and Antimicrobial Products

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VIREXX MEDICAL CORPORATION via MCKENNA, LONG & ALDRIDGE

2006 · mid_year · MM

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Pandemic Flu funding.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

VIREXX MEDICAL CORPORATION via MCKENNA, LONG & ALDRIDGE

2006 · year_end · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

IMPLICIT CORPORATION via MCKENNA, LONG & ALDRIDGE

2006 · mid_year · MM

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Funding for antiviral and antimicrobial products.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE